VAXNEUVANCE 4 ug/.5mL (Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed INJECTION, SUSPENSION) 4 ug/.5mL

VAXNEUVANCE 4 ug/0.5mL is a pneumococcal 15-valent conjugate vaccine designed for intramuscular administration. It helps protect against pneumococcal diseases caused by 15 serotypes. This vaccine is suitable for individuals seeking broad coverage against pneumococcal infections.

Strength

4 ug/.5mL

Pack Size

1 SYRINGE, GLASS in 1 CARTON (0006-4329-02) / .5 mL in 1 SYRINGE, GLASS (0006-4329-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VAXNEUVANCE 4 ug/0.5mL is used to prevent pneumococcal diseases, including infections caused by 15 different serotypes of the Streptococcus pneumoniae bacteria. This vaccine is often recommended for individuals who are at higher risk of pneumococcal infections, such as those with weakened immune systems or chronic health conditions. It is administered as an intramuscular injection and is part of a broader strategy to reduce the incidence of pneumococcal diseases.

Side Effects

Common effects of VAXNEUVANCE 4 ug/0.5mL may include mild to moderate reactions at the injection site, such as redness, swelling, or pain. Some individuals might experience general symptoms like fatigue, headache, or muscle aches. These effects are typically mild and resolve on their own within a few days. Severe reactions are rare but can occur, and medical attention should be sought if they do.

Precautions & Warnings

VAXNEUVANCE 4 ug/0.5mL should be handled with care, ensuring it is stored and administered according to the manufacturer's guidelines. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform healthcare providers about any existing medical conditions or medications before receiving the vaccine. Always follow the advice of a healthcare professional regarding the administration of this vaccine.

Avoid Interactions

VAXNEUVANCE 4 ug/0.5mL may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Alcohol and other substances that affect the immune system might influence the effectiveness of the vaccine, so it is important to consider these factors when planning vaccination.

Frequently Asked Questions

VAXNEUVANCE 4 ug/0.5mL is used to prevent pneumococcal diseases caused by 15 serotypes of the Streptococcus pneumoniae bacteria.

VAXNEUVANCE 4 ug/0.5mL is administered as an intramuscular injection.

Common effects may include mild to moderate reactions at the injection site, such as redness, swelling, or pain, as well as general symptoms like fatigue, headache, or muscle aches.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use.

It is advisable to discuss any current medications with a healthcare provider before receiving VAXNEUVANCE 4 ug/0.5mL.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.